32986-56-4NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)CC1ONLVFBUXFDBBNBW-UHFFFAOYSA-NSee also: Tobramycin (annotation moved to); Tobramycin Sulfate (annotation moved to); Fluorometholone acetate; tobramycin (annotation moved to) ... View More ...
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionTobramycin is one component (factor 6) of a mixture produced by fermentation of Streptomyces tenebrari us. Lacking the C-3′ hydroxyl group, it is not a substrate for APH(3′)-1 and APH(3′)-II and so has an intrinsically broader spectrum than kanamycin. It is a substrate, however, for adenylation at C-2′ by ANT (2′) and acetylation at C-3 by AAC(3)-I and AAC(3)-II and at C-2′ by AAC(2′).
Usesantibacterial, inhibits protein synthesis
UsesAntihypertensive
UsesTobramycin is an aminoglycoside antibiotic.
UsesSingle factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial
No reaction records under the current filter.
Loading…
32986-56-4CHEMBL14440DefinitionChEBI: A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring.